DEFINITIVE PROXY STATEMENT

Company

ENDRA Life Sciences Inc.

Filed

May 10, 2018

Period of Report

June 12, 2018

Accession Number

0001213900-18-005842

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →